These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3398072)

  • 1. Maintenance of androgen responsiveness by glucocorticoids in Shionogi mammary carcinoma cells in culture.
    Labrie F; Veilleux R; Fournier A
    J Natl Cancer Inst; 1988 Aug; 80(12):966-70. PubMed ID: 3398072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low androgen levels induce the development of androgen-hypersensitive cell clones in Shionogi mouse mammary carcinoma cells in culture.
    Labrie F; Veilleux R; Fournier A
    J Natl Cancer Inst; 1988 Sep; 80(14):1138-47. PubMed ID: 3411627
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential androgen sensitivity is associated with clonal heterogeneity in steroid metabolism, ornithine decarboxylase regulation and IL-1alpha action in mouse mammary tumor cells.
    Hida N; Poulin R; Veilleux R; Labrie F
    J Steroid Biochem Mol Biol; 1999 Nov; 71(1-2):71-81. PubMed ID: 10619359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A wide range of sensitivities to androgens develops in cloned Shionogi mouse mammary tumor cells.
    Labrie F; Veilleux R
    Prostate; 1986; 8(3):293-300. PubMed ID: 3703748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoids stimulate the growth of mouse mammary carcinoma Shionogi cells in culture.
    Labrie F; Veilleux R; Fournier A
    Mol Cell Endocrinol; 1988 Aug; 58(2-3):207-11. PubMed ID: 2850248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth-stimulating effect of pharmacological doses of glucocorticoid on androgen-responsive Shionogi carcinoma 115 in vivo in mice and in cell culture.
    Omukai Y; Nakamura N; Hiraoka D; Nishizawa Y; Uchida N; Noguchi S; Sato B; Matsumoto K
    Cancer Res; 1987 Aug; 47(16):4329-34. PubMed ID: 3607765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of steroid hormones and antihormones in cultured cells.
    Jung-Testas I; Baulieu EE
    Exp Clin Endocrinol; 1985 Dec; 86(2):151-64. PubMed ID: 2936615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenance of androgen-, glucocorticoid- or estrogen-responsive growth in shionogi carcinoma 115 subline sustained in castrated mice with high dose of estrogen for 30 generations (3 years).
    Fujita MQ; Yasui T; Sato B; Uchida N; Uchida K; Shiratori O; Takeda K; Matsumoto K
    Jpn J Cancer Res; 1992 Sep; 83(9):995-1001. PubMed ID: 1429212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of steroid hormones and opioid peptides on the growth of androgen-responsive Shionogi carcinoma (SC115) cells in primary culture.
    Jiang Y; Weinberg J; Wilkinson DA; Emerman JT
    Cancer Res; 1993 Sep; 53(18):4224-9. PubMed ID: 8364918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of different steroid hormones during progression of tumour cells to steroid autonomy.
    Darbre PD; King RJ
    Int J Cancer; 1987 Dec; 40(6):802-6. PubMed ID: 2826338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth stimulation by androgens, glucocorticoids or fibroblast growth factors and the blocking of the stimulated growth by antibody against basic fibroblast growth factor in protein-free culture of Shionogi carcinoma 115 cells.
    Tanaka A; Matsumoto K; Nishizawa Y; Lu J; Yamanishi H; Maeyama M; Nonomura N; Uchida N; Sato B
    J Steroid Biochem Mol Biol; 1990 Sep; 37(1):23-9. PubMed ID: 2242349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of antibody against basic fibroblast growth factor on androgen- or glucocorticoid-induced growth of Shionogi carcinoma 115 cells in serum-free culture.
    Lu J; Nishizawa Y; Tanaka A; Nonomura N; Yamanishi H; Uchida N; Sato B; Matsumoto K
    Cancer Res; 1989 Sep; 49(18):4963-7. PubMed ID: 2766270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mediation by the androgen receptor of the stimulatory and antiandrogenic actions of 17 beta-estradiol on the growth of androgen-sensitive Shionogi mammary carcinoma cells in culture.
    Luthy IA; Bégin D; Labrie F
    Endocrinology; 1988 Sep; 123(3):1418-24. PubMed ID: 3402389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth-stimulating effect of pharmacological doses of estrogen on androgen-dependent Shionogi carcinoma 115 in vivo but not in cell culture.
    Noguchi S; Nishizawa Y; Nakamura N; Uchida N; Yamaguchi K; Sato B; Kitamura Y; Matsumoto K
    Cancer Res; 1987 Jan; 47(1):263-8. PubMed ID: 3791211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucocorticoid-induced androgen inactivation by aldo-keto reductase 1C2 promotes adipogenesis in human preadipocytes.
    Veilleux A; Côté JA; Blouin K; Nadeau M; Pelletier M; Marceau P; Laberge PY; Luu-The V; Tchernof A
    Am J Physiol Endocrinol Metab; 2012 Apr; 302(8):E941-9. PubMed ID: 22275760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thyroid hormone (3,5,3'-triido-L-thyronine) masking/inversion of stimulatory effect of androgen on expression of mk1, a true tissue kallikrein, in the mouse submandibular gland.
    Kurihara K; Maruyama S; Nakanishi N; Sakagami H; Ueha T
    Endocrinology; 1999 Jul; 140(7):3003-11. PubMed ID: 10385392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of androgen resistance in mouse mammary tumor cells can be prevented by the antiandrogen flutamide.
    Luthy I; Labrie F
    Prostate; 1987; 10(1):89-94. PubMed ID: 3822919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability of androgen-related phenotypes in the Shionogi mammary carcinoma during growth, involution, recurrence, and progression to hormonal independence.
    Bruchovsky N; Rennie PS; Otal N; Vanson A; Giles M; Pontifex H
    Cancer Res; 1985 Feb; 45(2):682-9. PubMed ID: 3967243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory and stimulatory effects of glucocorticoid on androgen-induced growth of murine Shionogi carcinoma 115 in vivo and in cell culture.
    Hiraoka D; Nakamura N; Nishizawa Y; Uchida N; Noguchi S; Matsumoto K; Sato B
    Cancer Res; 1987 Dec; 47(24 Pt 1):6560-4. PubMed ID: 3677094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additive stimulatory action of glucocorticoids and androgens on basal and estrogen-repressed apolipoprotein-D messenger ribonucleic acid levels and secretion in human breast cancer cells.
    Simard J; de Launoit Y; Haagensen DE; Labrie F
    Endocrinology; 1992 Mar; 130(3):1115-21. PubMed ID: 1537279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.